Happy Tuesday Zingernation! Two of the past decade’s best-performing stocks have not been very fruitful or electrifying this year. Apple and Tesla are down about 7% and 25% respectively YTD, while the S&P 500 is up about 9% in the same time frame.

Apple was hit with a $2 billion fine from the EU. It doesn’t sound like too big of a bite out of a company worth nearly $3 trillion. But the market saw the EU’s decision, and its possible impact on Apple’s future App Store revenue, as a much bigger problem. More than $100 billion in market cap was wiped out in a single day of trading.

Before we dive in, check out the company that’s revolutionizing the way doctors treat colon cancer.

And, did someone forward you this email? Click here to subscribe to this Benzinga newsletter and more.

MARKET SNAPSHOT

Yesterday: We were groovin’ in the green all day until about 3 pm ET when a significant sell-off brought all major indices in the red. Chip names like $NVDA and $SMCI were leaders, while the aforementioned Tesla and Apple were laggards.

On Our Radar: Target reported before the open. We’ll hear from companies like Nordstrom, Crowdstrike, Chargepoint, and more after the close. The Fed Vice Chair will speak twice in the afternoon, at noon ET and 3:30 pm ET.

TOP STORY

Jim Cramer Tells Investors Why Bitcoin Is Rallying, And To 'Get Ready'

Briefly: Bitcoin crossed the $67,000 level for the first time since 2021 on Monday, adding another leg to the unrelenting rally over the last six months. CNBC’s Jim Cramer believes he knows what’s pushing the world’s largest cryptocurrency higher.

Reaching Higher: Bitcoin has been on a tear as of late, surging back towards the all-time highs it set in November 2021. Most have attributed the rally to increased demand stemming from recently approved spot Bitcoin ETFs, as well as anticipation of April's halving event. Cramer thinks something else is driving the buying.

Quoted: “I first thought the rally in Bitcoin was because of the ETFs,” Cramer said Monday. “I just think people are just saying ‘You know what, I don’t trust these fiat currencies.'”

Basically: Cramer explained that he believes Bitcoin is being used as a diversification hedge against the U.S. dollar and other fiat currencies. Fiat currencies are currencies lacking intrinsic value because they aren’t backed by a tangible asset like gold.

The Standard: The U.S. abandoned the gold standard in 1971, and the U.S. dollar has lost about 98% of its purchasing power in the 52 years since.

Learn More: Check out the full story here.  

PRESENTED BY ELICIO THERAPEUTICS

How Elicio Therapeutics Is Taking A Different Approach To Treating Cancers Like Colon Cancer, Expected To Be The Leading Killer Cancer By 2030

Elicio Therapeutics is at the forefront of cancer care with its AMP platform, transforming the landscape with cutting-edge immunotherapies. These innovations are designed not just to treat, but to strategically target and dismantle the very mutations that propel pancreatic and colon cancers.

The company's leading candidate, ELI-002, embodies this approach, aiming to deliver accessible, non-customized vaccines that promise a new dawn for cancer treatment efficacy and availability.

Though further studies are needed to confirm its efficacy, the shot could improve survival for colon cancer, expected to be the number one cause of cancer deaths for people between 20-49 years of age by 2030, and pancreatic cancer, which has just a 12% survival rate after five years.

There’s more, click here to keep reading.

FIVE ZINGERS

Upper Deck: $DECK bulls hit a homerun yesterday, with the footwear stock trading up to new all-time highs on its S&P 500 inclusion.

Stitches Or Riches? Buying the post-earnings dip on Stitch Fix could go either way for traders. Here’s what’s going on.

Here We Go Again: I thought all publicity was good publicity. Clearly not, as $NYCB is in the news again, and it ain’t lookin’ pretty.

Gold Mine: Digital gold isn’t the only thing breaking out to the upside. Good, old-fashioned analog gold is close to making new highs as well.

First Day Woes: A new Tesla Cyber Truck owner crashed his car on the very first day he owned it. And crashed it into a very famous hotel.

ONE FOR THE ROAD

'Oppenheimer' And 'Barbie' Success Could Mean Big Payouts For Bettors

Basically: Online major league sports betting has grown over the years, with more states legalizing it. Sports bettors have also been drawn to novel betting avenues like betting on political outcomes through cryptocurrency prediction markets. Bettors are also trying their luck predicting award show outcomes.

Barbenheimer: Two of the top-grossing movies in 2023 were released on the same day, creating a pop culture phenomenon. "Oppenheimer" and "Barbie" have also been among the most nominated movies on this year's movie awards circuit.

May The Best Flick Win: The two movies will face off in several categories, including for the iconic Best Picture award.

Heavy Favorite: "Oppenheimer" is a huge betting favorite at odds of -5000, which means a $1 bet would pay out a profit of only two cents if correct. The movie won the cast award for the Screen Actors Guild and Best Picture Drama at the Golden Globes.

What Next: Check out the full story here.

A MESSAGE FROM ELICIO THERAPEUTICS

Elicio Therapeutics (NASDAQ: ELTX) Reports Promising Progress In Cancer Vaccine Clinical Trials, Placing An Emphasis On The Lymphatic System

An estimated 609,820 people will die of cancer in the United States this year. Promising results from a 12-year-old clinical-stage biotechnology company have experts optimistic about the future of treating this deadly disease. 

With its proprietary Amphiphile or “AMP” platform, Elicio Therapeutics Inc. has developed multiple cancer vaccine candidates that concentrate an array of different immunogens in the lymph nodes. 

ELI-002 is Elicio’s lead clinical program for Kirsten rat sarcoma (KRAS) driven cancers caused by a mutation of the KRAS gene.

Click here to learn more and see what’s in store for Elicio Therapeutics in 2024.